Lung cancer study may fine-tune timing of radiation after pills
NCT ID NCT06613633
First seen Apr 30, 2026 · Last updated May 18, 2026 · Updated 3 times
Summary
This study watched 4,000 people with advanced lung cancer who had a specific gene change and were taking targeted pills. Researchers wanted to find the best time to add focused radiation to shrink remaining tumors. The goal is to learn how to combine treatments better, not to test a new drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200050, China
-
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
-
Wuhan Tongji Hospital
Wuhan, Hubei, 430030, China
Conditions
Explore the condition pages connected to this study.